SHANGHAI, March 11, 2024 /PRNewswire/ — The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai. The industry-leading tradeshow will draw nearly 5,000 global exhibitors from over 20 countries, with an expected audience of…
Month: March 2024
SHANGHAI, March 11, 2024 /PRNewswire/ — The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai. The industry-leading tradeshow will draw nearly 5,000 global exhibitors from over 20 countries, with an expected audience of…
DOHA, Qatar, March 11, 2024 /PRNewswire/ — In a significant development for the remittance sector, TerraPay, a global cross-border payments network, has announced a strategic partnership with Alfardan Exchange. This collaboration aims to leverage TerraPay’s advanced digital payment…
DOHA, Qatar, March 11, 2024 /PRNewswire/ — In a significant development for the remittance sector, TerraPay, a global cross-border payments network, has announced a strategic partnership with Alfardan Exchange. This collaboration aims to leverage TerraPay’s advanced digital payment…
BLAZE, a cloud-native microservices-based technology platform, was introduced during the Simply Payments event, a Leadership Connect Conference for financial services industry representatives BLAZE is designed to facilitate scalable and secure payment transactions, in sync with the…
BLAZE, a cloud-native microservices-based technology platform, was introduced during the Simply Payments event, a Leadership Connect Conference for financial services industry representatives BLAZE is designed to facilitate scalable and secure payment transactions, in sync with the…
STOCKHOLM, March 11, 2024 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (brand name: Leqembi®) at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™),…
STOCKHOLM, March 11, 2024 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (brand name: Leqembi®) at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™),…
STOCKHOLM, March 11, 2024 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (brand name: Leqembi®) at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™),…
STOCKHOLM, March 11, 2024 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (brand name: Leqembi®) at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™),…